The Advisory Board Company (NASDAQ:ABCO) announced that it will participate in the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, Nevada. The Advisory Board Company (NASDAQ:ABCO) shares after opening at $56.83 moved to $59.56 on last trade day and at the end of the day closed at $56.48. Company price to sales ratio in past twelve months was calculated as 4.06 and price to cash ratio as 38.01. The Advisory Board Company (NASDAQ:ABCO) showed a negative weekly performance of -1.91%.
Puma Biotechnology Inc. (NYSE:PBYI) plunged the most ever after a company-sponsored study found only a suggestion of benefit with its experimental drug for breast cancer in one group of women whose tumours are driven by a specific protein. Puma Biotechnology Inc. (NYSE:PBYI) shares fell -6.70% in last trading session and ended the day on $74.64. PBYI return on equity ratio is recorded as -54.10% and its return on assets is -44.80%. Puma Biotechnology Inc. (NYSE:PBYI) yearly performance is 131.08%.
SS and C Technologies Holdings Inc. (NASDAQ:SSNC) of Windsor reported record quarterly revenue Thursday after financial markets closed. Quarterly net income was $26.5 million, or 30 cents per share, compared with $21.4 million, or 26 cents per share. SS and C Technologies Holdings Inc. (NASDAQ:SSNC) shares moved up 6.19% in last trading session and was closed at $40.48, while trading in range of $37.76 – $40.98. SS and C Technologies Holdings Inc. (NASDAQ:SSNC) year to date (YTD) performance is -8.54%.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that members of the senior management team will present a corporate overview at Deutsche Bank Securities 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 4:10 p.m. ET at the InterContinental Hotel in Boston, MA. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) weekly performance is -1.47%. On last trading day company shares ended up $2.69. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) distance from 50-day simple moving average (SMA50) is -16.49%. Analysts mean target price for the company is $5.44.
Leave a Reply